Meaningful patient representation informing Canada’s cancer drug funding decisions: views of patient representatives on the Pan-Canadian Oncology Drug Review

Jeffrey S Hoch, M. B. Brown, C. McMahon, J. Nanson, J. Nanson, L. Rozmovits

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In this interview with the patient representatives on the Expert Review Committee (perc) of the Pan- Canadian Oncology Drug Review (pcodr), those representatives offer their views about how to be a valuable contributing member of Canada’s national cancer drug funding recommendation committee. The article seeks to inform readers, and especially clinicians, about pcodr from the perspective of the patient representatives.

Original languageEnglish (US)
Pages (from-to)263-266
Number of pages4
JournalCurrent Oncology
Volume21
Issue number5
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Patient Advocacy
Canada
Pharmaceutical Preparations
Neoplasms
Advisory Committees
Interviews

Keywords

  • Health economics
  • Oncology drug funding
  • Pcodr

ASJC Scopus subject areas

  • Oncology

Cite this

Meaningful patient representation informing Canada’s cancer drug funding decisions : views of patient representatives on the Pan-Canadian Oncology Drug Review. / Hoch, Jeffrey S; Brown, M. B.; McMahon, C.; Nanson, J.; Nanson, J.; Rozmovits, L.

In: Current Oncology, Vol. 21, No. 5, 2014, p. 263-266.

Research output: Contribution to journalArticle

@article{5b319fdc34f7476ebf5e0c72a42ba730,
title = "Meaningful patient representation informing Canada’s cancer drug funding decisions: views of patient representatives on the Pan-Canadian Oncology Drug Review",
abstract = "In this interview with the patient representatives on the Expert Review Committee (perc) of the Pan- Canadian Oncology Drug Review (pcodr), those representatives offer their views about how to be a valuable contributing member of Canada’s national cancer drug funding recommendation committee. The article seeks to inform readers, and especially clinicians, about pcodr from the perspective of the patient representatives.",
keywords = "Health economics, Oncology drug funding, Pcodr",
author = "Hoch, {Jeffrey S} and Brown, {M. B.} and C. McMahon and J. Nanson and J. Nanson and L. Rozmovits",
year = "2014",
doi = "10.3747/co.21.2128",
language = "English (US)",
volume = "21",
pages = "263--266",
journal = "Current Oncology",
issn = "1198-0052",
publisher = "Multimed Inc.",
number = "5",

}

TY - JOUR

T1 - Meaningful patient representation informing Canada’s cancer drug funding decisions

T2 - views of patient representatives on the Pan-Canadian Oncology Drug Review

AU - Hoch, Jeffrey S

AU - Brown, M. B.

AU - McMahon, C.

AU - Nanson, J.

AU - Nanson, J.

AU - Rozmovits, L.

PY - 2014

Y1 - 2014

N2 - In this interview with the patient representatives on the Expert Review Committee (perc) of the Pan- Canadian Oncology Drug Review (pcodr), those representatives offer their views about how to be a valuable contributing member of Canada’s national cancer drug funding recommendation committee. The article seeks to inform readers, and especially clinicians, about pcodr from the perspective of the patient representatives.

AB - In this interview with the patient representatives on the Expert Review Committee (perc) of the Pan- Canadian Oncology Drug Review (pcodr), those representatives offer their views about how to be a valuable contributing member of Canada’s national cancer drug funding recommendation committee. The article seeks to inform readers, and especially clinicians, about pcodr from the perspective of the patient representatives.

KW - Health economics

KW - Oncology drug funding

KW - Pcodr

UR - http://www.scopus.com/inward/record.url?scp=84907779408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907779408&partnerID=8YFLogxK

U2 - 10.3747/co.21.2128

DO - 10.3747/co.21.2128

M3 - Article

AN - SCOPUS:84907779408

VL - 21

SP - 263

EP - 266

JO - Current Oncology

JF - Current Oncology

SN - 1198-0052

IS - 5

ER -